HK Stock MarketDetailed Quotes

SINCO PHARMA (06833)

Watchlist
  • 0.170
  • 0.0000.00%
Market Closed Apr 15 09:00 CST
345.59MMarket Cap8.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SINCO PHARMA (06833) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
进口药品销售2.06B98.99%
医美服务21.03M1.01%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
进口药品销售2.06B98.99%
医美服务21.03M1.01%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
China2.08B100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 -0.84%
Sample Name
Sample Code
 -6.10%
Sample Name
Sample Code
 -6.20%
4
SHANGHAI PECHEM
00338
-10.56%
5
YANCHANG PETRO
00346
-11.83%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +23.12%
Sample Name
Sample Code
 +22.06%
Sample Name
Sample Code
 +16.30%
4
Hangzhou Shunwang Technology
300113
+12.45%
5
Ucloud Technology Co., Ltd
688158
+9.55%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -